Skip to main content

Table 2 Clinical and demographic characteristics of recurrent TB cases treated for drug susceptible TB in Zambia, southern province

From: Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia

CharacteristicLevelTotalUrban areasRural areas
  n (percent)n (percent)n (percent)
SexFemale1482 (41.7)1045 (40.7)437 (44.1)
male2019 (56.9)1473 (57.4)546 (55.2)
Missing54 (1.52)47 (1.8)7 (0.7)
Age groupa10 & below128 (3.6)93 (3.6)35 (3.5)
11–18140 (3.9)103 (4.0)37 (3.7)
19–552185 (79.2)2064 (80.5)751 (75.9)
56 & older403 (11.3)259 (10.1)144 (14.6)
Missing69 (1.9)46 (1.8)23 (2.3)
Microbiological confirmationclinical2519 (70.9)1874 (73.1)639 (64.6)
confirmed1036 (29.1)689 (26.9)347 (35.1)
Reason for retreatmentRelapse patients2745 (77.2)2126 (82.9)619 (62.5)
Other644 (18.1)330 (12.9)314 (31.7)
Treatment after LTFU patients31 (0.8)28 (1.1)3 (0.3)
Treatment after failure patients29 (0.82)15 (0.6)14 (1.4)
Missing106 (3.0)66 (2.6)40 (4.0)
Site of diseasePulmonary2937 (82.6)2086 (81.3)851 (86.0)
Extra-pulmonary537 (15.1)418 (16.3)119 (12.0)
Missing81 (2.3)61 (2.4)20 (2.0)
Treatment Delay14 days & less3135 (88.2)2286 (89.1)849 (85.8)
15 days and more420 (11.8)279 (10.9)141 (14.2)
Calendar year< 20101884 (53)1336 (52.1)548 (55.4)
2010 & after1671 (47)1229 (47.9)442 (44.7)
Facility typeHospital1353 (38.1)926 (36.1)427 (43.1)
Health Center or clinic2202 (61.9)1639 (63.9)563 (56.9)
HIV statusNegative1382 (38.9)853 (61.7)529 (38.3)
Positive2173 (61.1)1712 (78.8)461 (21.2)
  1. aAge group (< 10, 11–18, 19–55 and > 55) classification was based a WHO pediatric treatment guidelines and other previous studies of TB treatment outcomes [13, 14].